Brevundimonas spp. infection in immunocompromised children: Two case reports

Andreé Altamirano-Beltrán, Christian Chiara-Chilet, José W. López, Maria J. Pons, Julio Maquera-Afaray

Producción científica: Contribución a una revistaArtículorevisión exhaustiva


Introduction Brevundimona spp. are rare and opportunistic pathogens which may cause infections in patients who are immunocompromised or have underlying disease. Case report Two cases with a microbiological diagnosis of Brevundimonas aurantiaca and Brevundimonas spp. are presented. Both occurred in immunocompromised patients with post-chemotherapy febrile neutropenia for B-type acute lymphoblastic leukemia and hepatoblastoma. Antibiogram findings showed resistance to quinolones, ceftazidime, and intermediate resistance to cefepime, being susceptible to carbapenems and aminoglycosides. The cases responded favorably to the administration of carbapenem. Conclusions The identification of the species and antimicrobial susceptibility profile favor response to infection, denoting the importance of species identification and the performance of an antibiogram to determine the different susceptibility profiles described in the literature on this emerging pathogen.

Idioma originalInglés
Páginas (desde-hasta)72-79
Número de páginas8
EstadoPublicada - 2023


Profundice en los temas de investigación de 'Brevundimonas spp. infection in immunocompromised children: Two case reports'. En conjunto forman una huella única.

Citar esto